Editorial Commentary
Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
Translational Lung Cancer Research
2025;
14
(1)
:1-6
.
(24 January 2025)
Advancing leptomeningeal metastases treatment in EGFR-mutated non-small cell lung cancer: lessons from the BLOSSOM trial
Translational Lung Cancer Research
2025;
14
(1)
:7-13
.
(24 January 2025)
Original Article
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(1)
:14-26
.
(24 January 2025)
Patient-reported outcomes in the early postoperative period following resection of unilateral multiple pulmonary nodules: implications for surgical decision-making
Translational Lung Cancer Research
2025;
14
(1)
:27-39
.
(24 January 2025)
Anlotinib enhances the anti-tumor activity of osimertinib in patients with non-small cell lung cancer by reversing drug resistance
Translational Lung Cancer Research
2025;
14
(1)
:40-57
.
(24 January 2025)
Video-assisted mediastinocopic lymphadenectomy (VAMLA) for restaging clinical N2–3 non-small cell lung cancer (NSCLC) after neoadjuvant treatment
Translational Lung Cancer Research
2025;
14
(1)
:58-71
.
(24 January 2025)
Association between immunotherapy timing and efficacy in non-small cell lung cancer: a comprehensive analysis at a high-volume specialist centre
Translational Lung Cancer Research
2025;
14
(1)
:72-80
.
(24 January 2025)
A novel optimization of cone beam CT frequency for lung radiation therapy based on an image-guided radiation therapy protocol and patient classification method
Translational Lung Cancer Research
2025;
14
(1)
:81-95
.
(24 January 2025)
Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study
Translational Lung Cancer Research
2025;
14
(1)
:96-106
.
(24 January 2025)
SMARCA4/BRG1-deficient non-small cell lung cancer: clinical, imaging, pathological features, and follow-up results of 23 patients
Translational Lung Cancer Research
2025;
14
(1)
:107-123
.
(24 January 2025)
Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions
Translational Lung Cancer Research
2025;
14
(1)
:124-138
.
(24 January 2025)
Efficacy of adjuvant tegafur-uracil (UFT) in early-stage non-small cell lung cancer with poor prognostic factors
Translational Lung Cancer Research
2025;
14
(1)
:139-149
.
(24 January 2025)
Deep learning-based lung cancer risk assessment using chest computed tomography images without pulmonary nodules ≥8 mm
Translational Lung Cancer Research
2025;
14
(1)
:150-162
.
(24 January 2025)
Efficacy and safety of first-line immunotherapy-based regimens for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis
Translational Lung Cancer Research
2025;
14
(1)
:163-175
.
(24 January 2025)
Association of systemic therapy with survival among adults with advanced non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(1)
:176-193
.
(24 January 2025)
The utility and feasibility of three-dimensional reconstruction in surgical planning for multiple pulmonary nodules: a prospective self-controlled study
Translational Lung Cancer Research
2025;
14
(1)
:194-208
.
(24 January 2025)
Single-cell and spatial transcriptomics reveal a potential role of ATF3 in brain metastasis of lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(1)
:209-223
.
(24 January 2025)
MS4A15 gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(1)
:224-238
.
(24 January 2025)
GNGT1 remodels the tumor microenvironment and promotes immune escape through enhancing tumor stemness and modulating the fibrinogen beta chain-neutrophil extracellular trap signaling axis in lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(1)
:239-259
.
(24 January 2025)
Intraoperative longitude-latitude-depth three-dimensional localization of pulmonary nodules
Translational Lung Cancer Research
2025;
14
(1)
:260-271
.
(24 January 2025)
Case Report: iMDT Corner
Reirradiation using helical tomotherapy-based hypofractionated stereotactic radiotherapy for 19 brain metastases after the second recurrence of distant brain failure: a case report and literature review
Translational Lung Cancer Research
2025;
14
(1)
:272-286
.
(24 January 2025)
Case Report
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case report
Translational Lung Cancer Research
2025;
14
(1)
:287-291
.
(24 January 2025)
Hyperthermic intrathoracic chemotherapy in overcoming tyrosine kinase inhibitor resistance in a patient with malignant pleural effusion: a case report
Translational Lung Cancer Research
2025;
14
(1)
:292-299
.
(24 January 2025)
Letter to the Editor
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(1)
:300-302
.
(24 January 2025)
Methodological aspects of studies on survival after immunotherapy in stage IV non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(1)
:303-304
.
(24 January 2025)
